close
close

The craniosacral and maxillofacial devices market is poised to witness remarkable growth at 8.8% CAGR by 2032.

Posted on by darion

Valued at $1.7 billion in 2022, the global craniosacral and maxillofacial devices market is projected to reach $3.9 billion by 2032, reflecting a solid CAGR of 8.8% from 2023- 2032. This increase can be attributed to several factors, including the increasing incidence of facial fractures and congenital facial deformities, advances in surgical techniques, and the increasing use of craniosacral implants.

However, the market faces challenges such as the high cost of surgical procedures and the risk of complications associated with these devices. Recent developments in the market include the introduction of 3D printing technology for personalized implants and improvements in bioresorbable materials, which are expected to continue to drive market growth.

Key takeaways

  • The market is expected to develop at approx CAGR of 8.8% from 2023 to 2032, reaching $3.9 billion until 2032.
  • The increasing number of cases of facial injuries, especially among men, is a significant factor for the market growth.
  • High surgical costs and shortage of qualified surgeons are the main obstacles limiting market expansion.
  • Emerging economies such as India and China offer growth opportunities through increased investment in healthcare.
  • Progress in research and development and development of deep brain stimulation procedures are supporting the market growth.
  • The largest share is the CMF dispersion segment, used in the correction of deformities, sports injuries and facial fractures.
  • Metal implants dominate due to their cost-effectiveness and stiffness, but bioabsorbable materials are expected to develop the fastest.
  • The main end users are hospitals, with a large number of patients and surgeons opting for craniosacral surgery.
  • North America leads the global market, driven by advanced implants, corrective surgery awareness and a strong healthcare base.
  • The Asia-Pacific region is expected to experience the fastest growth, supported by improving healthcare infrastructure and growing patient awareness.

Download a sample report in PDF format: https://market.us/report/craniosaxillofacial-devices-market/request-sample/

Key segments of the craniosacral and maxillofacial devices market

Based on type

  • Bone graft substitute
  • CMF plate and screw mounting
  • Temporomandibular joint replacement
  • Others

Based on the application

  • Neurosurgery
  • Orthognathic and dental surgery
  • cosmetic surgery
  • Others

Based on the material

  • Metal
  • Bioabsorbable material
  • Ceramic
  • Others

Based on end users

  • Hospitals
  • Grey’s Anatomy
  • Outpatient surgery centers
  • Others

Key Regions

  • North America (USA, Canada, Mexico)
  • Western Europe (Germany, France, UK, Spain, Italy, Portugal, Ireland, Austria, Switzerland, Benelux, Nordic countries, rest of Western Europe)
  • Eastern Europe (Russia, Poland, Czech Republic, Greece, rest of Eastern Europe)
  • APAC (China, Japan, South Korea, India, Australia and New Zealand, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, rest of APAC)
  • Latin America (Brazil, Colombia, Chile, Argentina, Costa Rica, rest of Latin America)
  • Middle East and Africa (Algeria, Egypt, Israel, Kuwait, Nigeria, Saudi Arabia, South Africa, Turkey, United Arab Emirates, rest of MEA)

Buy Directly: https://market.us/purchase-report/?report_id=100753

Analysis of key players

DePuy Synthes, part of Johnson & Johnson, is a leading player in the craniosacral maxillofacial (CMF) device market. The company offers a comprehensive portfolio of products intended for reconstructive surgery of the face, skull and jaw. Their offer includes innovative implants and instruments used in trauma surgery, orthognathic surgery and reconstructive procedures. DePuy Synthes is known for its commitment to improving patient outcomes through extensive research and development, using the latest technologies to improve surgical precision and reduce recovery time.

Stryker Corporation is a leading brand in the CMF industry, providing a wide range of facial and cranial reconstruction solutions. The company’s product line includes customizable implants, surgical instruments and advanced fixation systems. Stryker CMF devices are known for their quality and reliability, which is crucial for complex surgical procedures. Stryker’s continued focus on innovation and collaboration with healthcare professionals ensures they remain at the forefront of developing cutting-edge CMF solutions.

Medtronic is a key player in the CMF device market, offering a wide range of products for the treatment of facial trauma, deformity and reconstruction. Their portfolio includes titanium plates and screws, resorbable implants and other specialized surgical tools. Medtronic emphasizes technological advancements and the precision of its devices with the goal of improving surgical outcomes and patient safety. The company’s commitment to continuous improvement and innovation positions it as a trusted supplier in the CMF industry.

Braun Melsungen AG is known for its significant contributions to the CMF market. The company offers a wide range of products tailored to cranial and maxillofacial surgery, including plates, screws and instruments designed for complex reconstructions. Braun appliances are known for their high standards of quality and reliability. The company’s commitment to innovation and customer-centric solutions ensures they meet the evolving needs of surgeons and patients in the CMF sector.

Renishaw is a notable player in the CMF market, particularly recognized for its advanced manufacturing and customization capabilities. The company offers patient-specific implants and state-of-the-art surgical guides that increase the precision of CMF surgery. Renishaw’s use of 3D printing technology enables the creation of bespoke implants that fit each patient’s unique anatomy, leading to better surgical outcomes. Their focus on innovation and personalized solutions makes them a significant contributor to the CMF device industry.

Key players in the craniosacral and maxillofacial devices market:

  • DePuy Synthes (J&J)
  • Stryker company
  • Medtronic
  • Braun Melsungen AG
  • Renishaw Company
  • Medartis AG
  • KLS Martin Group
  • Xilloc Medical BV
  • Synchronized
  • Zimmer-Biomet
  • Other key players

Scope of the report on the craniosacral and maxillofacial devices market >> Market value (2022): $1.7 billion || Projected revenues (2032): $3.9 billion || CAGR (2023–2032): 8.8% || Estimated base year: 2023 || Historical period: 2019-2022 || Forecast period: 2024-2033.

Ask more about the report: https://market.us/report/craniosaxillofacial-devices-market/#inquiry

About Market.US

Market.US is renowned for its comprehensive market research and analysis, providing customized and syndicated reports to clients around the world. Specializing in various sectors, they offer strategic insights and detailed market forecasts, helping companies make informed decisions. With a focus on innovation and accuracy, Market.US supports customers in over 126 countries and maintains a high percentage of repeat customers, emphasizing their commitment to quality and customer satisfaction. Their team specializes in providing exceptional research services, ensuring that no detail is overlooked in any target market.

Contact details
Market.us (operated by Prudour Pvt. Ltd.)
Contact number: +1 718 618 4351.
E-mail: [email protected]
Blog: https://medicalmarketreport.com/

See more trend reports

The robotic prosthetics market is expected to reach USD 3,212 million by 2032

The value of generative AI in the healthcare market will reach $17.2 billion by 2032

By 2032, the telecare market is expected to reach $6.8 billion

Face mask machine market projected to reach $27.4 billion by 2032

The intravascular ultrasound (IVUS) device market will reach $1,296 million by 2032.